Navigation Links
TheraBiogen, Inc. Relocates Corporate Headquarters to New Jersey
Date:12/5/2011

NEW YORK, Dec. 5, 2011 /PRNewswire/ -- TheraBiogen, Inc. (OTC BB: TRAB), a manufacturer and distributor of homeopathic nasal sprays for aiding in the relief of allergies, cold and flu symptoms and migraine headaches, today announced the relocation of its corporate headquarters to New Jersey.

The new facility located at 4400 Route 9 South in Manalapan, New Jersey will accommodate the Company's current staff and enable further expansion for the Company's future growth.

Kelly Hickel, CEO of TheraBiogen, commented, "As the demand for our products continues to grow, we have decided to relocate our corporate offices to New Jersey where we will have the capacity to expand with lower operating costs and more flexibility."  He added, "It is an added benefit to be located in New Jersey, the heart of America's pharmaceutical and over the counter drug industry."

Thera Max is available for purchase in over twelve thousand locations including Rite-Aid, Food Lion, Hannaford Supermarkets, Discount Drug Marts, Big Y Supermarkets and others.  For more information on Thera Max visit our website at www.theramaxrelief.com, our  Facebook page at facebook.com/theramaxnasalspray or follow us on Twitter at http://twitter.com/TheraMaxRelief.

About TheraBiogen, Inc.TheraBiogen is a manufacturer and distributor of homeopathic nasal sprays for aiding in the relief of allergies, cold and flu symptoms and migraine headaches. The products are made from natural, homeopathic ingredients and contain no zinc, which has been identified as potentially causing nasal problems in other similar products on the market. For further information please visit www.theramaxrelief.com.

Safe Harbor Statement

This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21 E of the Securities Exchange Act of 1934, as amended. Investors are cautioned that these forward-looking statements involve uncertainties and risk that could cause actual performance and results of operations to differ materially from those anticipated. These risks are set forth in the Company's most recently filed form 10-K and Form 10-Q reports. TheraBiogen, Inc. assumes no obligation to update the statements contained in this release except as required by applicable securities laws disclosure rules.Company Contact: Public Relations Contact: Investor Contact:TheraBiogen, Inc. 

Megan Megale 

Boutcher & BoutcherKelly T. Hickel, CEO 

Megale Public Relations 

Aimee Boutcher732-294-8705 

703-625-8093

973-239-2878kthickel@therabiogen.com 

mmegale@megalepr.com

 


'/>"/>
SOURCE TheraBiogen, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Rochester Medical Implants Relocates to New Facility in Noblesville, IN
2. The Pittsburgh Life Sciences Greenhouse Relocates Therapeutics Company to Pittsburgh
3. Ferring Pharmaceuticals To Develop Major Corporate Center in Parsippany, New Jersey
4. White Smile Global Inc. Corporate Update on the White Smile Premier™ "At-Home" LED Teeth Whitening System and the White Smile Tooth Gloss™, Including Clinical Study, Product Manufacturing, and Distribution
5. Accuray Incorporateds CEO to Speak at Lazard Capital Markets 8th Annual Healthcare Conference and Stephens Fall Investment Conference
6. Abbott Honored With Scrip Award for Leadership in Corporate Social Responsibility
7. Champions Oncology, Inc. Appoints Executive Vice President and Chief Financial Officer to Management Team and Corporate Office Relocation
8. ZONARE Medical Systems Announces Appointment of PJ Ryland as Vice President of Business Development & Corporate Accounts
9. ViroPharma Incorporated Reports Third Quarter 2011 Financial Results
10. nContact, Inc. Launches New Corporate Websites
11. Accuray Incorporated to Report Financial Results for First Quarter of Fiscal 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... 2017  Luminex Corporation (NASDAQ: LMNX ) (the ... the initiation of a quarterly cash dividend to its shareholders, ... will be payable on April 14, 2017 to shareholders of ... 2017. The board of directors intends for ... $0.06 to holders of its common stock, representing a planned ...
(Date:2/21/2017)... 2017 Medical Oxygen Concentrators Market: Overview ... Medical oxygen concentrators are used by ... Patients having low level of oxygen in their ... concentrators are to be used only with prescription ... oxygen concentrators work either on rechargeable lithium batteries ...
(Date:2/21/2017)... 2017 Scientists From Two Companies ... Plastic Industry  ... STEER, creator of advanced materials platform ... fields of plastics, pharmaceuticals, food and nutraceuticals, biomaterials and biorefining, ... Germany , a leading science & ...
Breaking Medicine Technology:
(Date:2/21/2017)... , ... February 21, 2017 , ... ... acquisition of the predictive analytic firm Predixion’s Healthcare IT practice. Predixion, which raised ... and is backed by giants including Accenture, GE Ventures, and Software AG ...
(Date:2/21/2017)... ... 21, 2017 , ... Along with Valentine’s Day, February marks American Heart Month, ... can lead to a lifetime of heart health. In addition, it is a ... , The Athletic Trainers’ Society of New Jersey (ATSNJ) is urging sports programs to ...
(Date:2/20/2017)... ALEXANDRIA, VA (PRWEB) , ... February 20, 2017 , ... ... with Cambridge Healthcare to open and operate a state-of-the-art memory care community in Alexandria, ... of 2018 on a site just outside of Old Town. , The three-story ...
(Date:2/20/2017)... ... February 20, 2017 , ... The StayWell Company and ... providers better manage patient health risks, foster behavior change and improve health literacy among ... world, will present a demonstration of its video capability at StayWell booth 3443 during ...
(Date:2/20/2017)... ... February 20, 2017 , ... Houston dentist , Dr. ... care at his office, Antoine Dental Center. Emergency dentistry encompasses many treatments for ... at risk for serious complications and often experience severe pain. Not only does ...
Breaking Medicine News(10 mins):